SCHEMBL17455126

SCHEMBL17455126

NC[C@@H](Cc1cccnc1)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.81
CYP2D6 P10635 5/20 0.81
SLC6A2 P23975 5/20 0.81
SLC6A4 P31645 5/20 0.81
SLC6A3 Q01959 5/20 0.81
KCNH2 Q12809 3/20 0.70
P2RX7 Q99572 1/20 0.46
ALDH1A1 P00352 3/20 0.41
MEN1 O00255 2/20 0.41
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
HTT P42858 2/20 0.41
KMT2A Q03164 2/20 0.41
HPGD P15428 1/20 0.41
RAB9A P51151 1/20 0.41
CHRNA7 P36544 1/20 0.41
CYP2A6 P11509 1/20 0.40
FDPS P14324 1/20 0.39
PKM P14618 1/20 0.38
HRH1 P35367 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16114403 1.00 CYP3A4 (0.81) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
Hydrochloric Acid SCHEMBL17455174 0.99 CYP3A4 (0.79) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL17471758 0.89 CYP3A4 (1.00) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL20052821 0.89 CYP3A4 (1.00) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL17455256 0.83 SLC6A2 (1.00) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL17455258 0.83 SLC6A2 (1.00) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL17455335 0.83 SLC6A2 (1.00) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL9222317 0.82 SLC6A2 (0.55) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL5849664 0.78 CYP3A4 (0.51) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
Hydrochloric Acid SCHEMBL5848397 0.77 CYP3A4 (0.50) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9944618-B2 Inhibiting neurotransmitter reuptake MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2018-04-17 US disclosed
US-20160024044-A1 INHIBITING NEUROTRANSMITTER REUPTAKE MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2016-01-28 US disclosed
US-20160024044-A1 INHIBITING NEUROTRANSMITTER REUPTAKE MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2016-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160024044-A1 INHIBITING NEUROTRANSMITTER REUPTAKE SLC6A2, SLC18A2, SLC6A4 CYP3A4 1644/4885CYP2D6 910/4885SLC6A2 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.